We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sphere Medical | LSE:SPHR | London | Ordinary Share | GB00B551W951 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.40 | 0.35 | 0.45 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSPHR
RNS Number : 6236I
Sphere Medical Holding plc
01 September 2016
1 September 2016
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
Notice of Interim Results
Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, will announce its interim results for the six months ended 30 June 2016 on Thursday 22 September 2016.
Dr. Wolfgang Rencken, Chief Executive Officer and Richard Wright, Chief Financial Officer, will host a presentation and conference call for analysts at 11:00 BST on the day of the results at 85 Gresham Street, London, EC2R 7HE.
- Ends -
For further information, please contact:
Sphere Medical Holding plc Tel: +44 (0)1223 875 222 Dr Wolfgang Rencken, Chief Executive Officer Richard Wright, Chief Financial Officer Panmure Gordon Tel: +44 (0) 20 7886 2500 Freddy Crossley (Corporate Finance) Duncan Monteith (Corporate Finance) Tom Salvesen (Corporate Broking) Consilium Strategic Communications Tel: +44 (0) 20 3709 5700 Mary-Jane Elliott spheremedical@consilium-comms.com Chris Gardner Ivar Milligan Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its Proxima(TM) platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is currently sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium. For further information, please visit www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORLLFFDTLILVIR
(END) Dow Jones Newswires
September 01, 2016 02:00 ET (06:00 GMT)
1 Year Sphere Medical Chart |
1 Month Sphere Medical Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
